Name: Global Therapeutic Radioisotopes Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.8 (138 reviews)

Global Therapeutic Radioisotopes Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research has published the global report on the Therapeutic Radioisotopes Market, which consists of insights about all the important parameters of the market such as consumption and the production patterns coupled with the revenue patterns for the forecast period. In terms of production aspect, the report offers complete detailed analysis regarding the manufacturing processes coupled with the gross financials gathered by the top most manufacturers functioning in this industry. The primary aspect of the Therapeutic Radioisotopes market that is covered in the report assists the clients and the organizations to better understand the business profile in terms of drivers, restraints, challenges, and opportunities pertaining and affecting the market dynamics.

Data provided by Extent Research. Source: https://www.extentresearch.com/therapeutic-radioisotopes-market

According to the Therapeutic Radioisotopes report, the market is projected to expand with a CAGR of XX% during the forecast period 2026 to 2035.

COVID-19 has majorly affected the overall global businesses and it will take a huge time for the business recovery. Majority of the industry sectors have realigned their business strategies, priorities, and have amended their economic planning in order to remain in the business and retain their position on the global platform. The exhaustive analysis of the Therapeutic Radioisotopes market will help the new market entrants to obtain reliable market strategies and plan strong action plans for the forecast period.

Furthermore, the market segmentation that is included in the report is by Product type Radium-223, Lutetium-177, Iodine-131, Other, , by Application Thyroid, Bone Metastasis, Lymphoma, Other, . The major market players that are enlisted within the report are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus, Spectrum Pharmaceuticals, Progenics Pharmaceuticals, International Isotopes, .

Major highlights of the Therapeutic Radioisotopes market report:

COVID-19 impact on the revenue streams of the Therapeutic Radioisotopes market players.
Statistics of the total sales volume and overall market revenue.
Industry trends breakdowns.
Estimated growth rate of the Therapeutic Radioisotopes market.
Pros and cons of the direct and indirect sales channels.
In-depth information about the major distributors, dealers, and traders.

Report Scope and Market Segmentation

ATTRIBUTES	Global Therapeutic Radioisotopes Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Therapeutic Radioisotopes Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Therapeutic Radioisotopes Product Introduction
    1.2 Market by Type
        1.2.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Radium-223
        1.2.3 Lutetium-177
        1.2.4 Iodine-131
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2017-2035
    2.2 Global Therapeutic Radioisotopes Revenue Estimates and Forecasts 2017-2035
    2.3 Global Therapeutic Radioisotopes Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Therapeutic Radioisotopes Sales by Region
        2.4.1 Global Therapeutic Radioisotopes Sales by Region (2017-2022)
        2.4.2 Global Sales Therapeutic Radioisotopes by Region (2023-2035)
    2.5 Global Therapeutic Radioisotopes Revenue by Region
        2.5.1 Global Therapeutic Radioisotopes Revenue by Region (2017-2022)
        2.5.2 Global Therapeutic Radioisotopes Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Therapeutic Radioisotopes Sales by Manufacturers
        3.1.1 Global Top Therapeutic Radioisotopes Manufacturers by Sales (2017-2022)
        3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radioisotopes in 2021
    3.2 Global Therapeutic Radioisotopes Revenue by Manufacturers
        3.2.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2017-2022)
        3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2021
    3.3 Global Therapeutic Radioisotopes Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Therapeutic Radioisotopes Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Therapeutic Radioisotopes Sales by Type
        4.1.1 Global Therapeutic Radioisotopes Historical Sales by Type (2017-2022)
        4.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Type (2023-2035)
        4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2035)
    4.2 Global Therapeutic Radioisotopes Revenue by Type
        4.2.1 Global Therapeutic Radioisotopes Historical Revenue by Type (2017-2022)
        4.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2035)
    4.3 Global Therapeutic Radioisotopes Price by Type
        4.3.1 Global Therapeutic Radioisotopes Price by Type (2017-2022)
        4.3.2 Global Therapeutic Radioisotopes Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Therapeutic Radioisotopes Sales by Application
        5.1.1 Global Therapeutic Radioisotopes Historical Sales by Application (2017-2022)
        5.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Application (2023-2035)
        5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2035)
    5.2 Global Therapeutic Radioisotopes Revenue by Application
        5.2.1 Global Therapeutic Radioisotopes Historical Revenue by Application (2017-2022)
        5.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2017-2035)
    5.3 Global Therapeutic Radioisotopes Price by Application
        5.3.1 Global Therapeutic Radioisotopes Price by Application (2017-2022)
        5.3.2 Global Therapeutic Radioisotopes Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Therapeutic Radioisotopes Market Size by Type
        6.1.1 North America Therapeutic Radioisotopes Sales by Type (2017-2035)
        6.1.2 North America Therapeutic Radioisotopes Revenue by Type (2017-2035)
    6.2 North America Therapeutic Radioisotopes Market Size by Application
        6.2.1 North America Therapeutic Radioisotopes Sales by Application (2017-2035)
        6.2.2 North America Therapeutic Radioisotopes Revenue by Application (2017-2035)
    6.3 North America Therapeutic Radioisotopes Market Size by Country
        6.3.1 North America Therapeutic Radioisotopes Sales by Country (2017-2035)
        6.3.2 North America Therapeutic Radioisotopes Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Therapeutic Radioisotopes Market Size by Type
        7.1.1 Europe Therapeutic Radioisotopes Sales by Type (2017-2035)
        7.1.2 Europe Therapeutic Radioisotopes Revenue by Type (2017-2035)
    7.2 Europe Therapeutic Radioisotopes Market Size by Application
        7.2.1 Europe Therapeutic Radioisotopes Sales by Application (2017-2035)
        7.2.2 Europe Therapeutic Radioisotopes Revenue by Application (2017-2035)
    7.3 Europe Therapeutic Radioisotopes Market Size by Country
        7.3.1 Europe Therapeutic Radioisotopes Sales by Country (2017-2035)
        7.3.2 Europe Therapeutic Radioisotopes Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Therapeutic Radioisotopes Market Size by Type
        8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Type (2017-2035)
        8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Type (2017-2035)
    8.2 Asia Pacific Therapeutic Radioisotopes Market Size by Application
        8.2.1 Asia Pacific Therapeutic Radioisotopes Sales by Application (2017-2035)
        8.2.2 Asia Pacific Therapeutic Radioisotopes Revenue by Application (2017-2035)
    8.3 Asia Pacific Therapeutic Radioisotopes Market Size by Region
        8.3.1 Asia Pacific Therapeutic Radioisotopes Sales by Region (2017-2035)
        8.3.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Therapeutic Radioisotopes Market Size by Type
        9.1.1 Latin America Therapeutic Radioisotopes Sales by Type (2017-2035)
        9.1.2 Latin America Therapeutic Radioisotopes Revenue by Type (2017-2035)
    9.2 Latin America Therapeutic Radioisotopes Market Size by Application
        9.2.1 Latin America Therapeutic Radioisotopes Sales by Application (2017-2035)
        9.2.2 Latin America Therapeutic Radioisotopes Revenue by Application (2017-2035)
    9.3 Latin America Therapeutic Radioisotopes Market Size by Country
        9.3.1 Latin America Therapeutic Radioisotopes Sales by Country (2017-2035)
        9.3.2 Latin America Therapeutic Radioisotopes Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Type
        10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Type (2017-2035)
    10.2 Middle East and Africa Therapeutic Radioisotopes Market Size by Application
        10.2.1 Middle East and Africa Therapeutic Radioisotopes Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Application (2017-2035)
    10.3 Middle East and Africa Therapeutic Radioisotopes Market Size by Country
        10.3.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bayer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Corporation Information
        11.2.2 Novartis Overview
        11.2.3 Novartis Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis Recent Developments
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Corporation Information
        11.3.2 China Isotope & Radiation Overview
        11.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 China Isotope & Radiation Recent Developments
    11.4 Dongcheng
        11.4.1 Dongcheng Corporation Information
        11.4.2 Dongcheng Overview
        11.4.3 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Dongcheng Recent Developments
    11.5 Q BioMed
        11.5.1 Q BioMed Corporation Information
        11.5.2 Q BioMed Overview
        11.5.3 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Q BioMed Recent Developments
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Corporation Information
        11.6.2 Curium Pharmaceuticals Overview
        11.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Curium Pharmaceuticals Recent Developments
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Corporation Information
        11.7.2 Jubilant DraxImage Overview
        11.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Jubilant DraxImage Recent Developments
    11.8 Lantheus
        11.8.1 Lantheus Corporation Information
        11.8.2 Lantheus Overview
        11.8.3 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lantheus Recent Developments
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Corporation Information
        11.9.2 Spectrum Pharmaceuticals Overview
        11.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Spectrum Pharmaceuticals Recent Developments
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Corporation Information
        11.10.2 Progenics Pharmaceuticals Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Progenics Pharmaceuticals Recent Developments
    11.11 International Isotopes
        11.11.1 International Isotopes Corporation Information
        11.11.2 International Isotopes Overview
        11.11.3 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Therapeutic Radioisotopes Industry Chain Analysis
    12.2 Therapeutic Radioisotopes Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Therapeutic Radioisotopes Production Mode & Process
    12.4 Therapeutic Radioisotopes Sales and Marketing
        12.4.1 Therapeutic Radioisotopes Sales Channels
        12.4.2 Therapeutic Radioisotopes Distributors
    12.5 Therapeutic Radioisotopes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Therapeutic Radioisotopes Industry Trends
    13.2 Therapeutic Radioisotopes Market Drivers
    13.3 Therapeutic Radioisotopes Market Challenges
    13.4 Therapeutic Radioisotopes Market Restraints
14 Key Findings in The Global Therapeutic Radioisotopes Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Therapeutic Radioisotopes Market